CELLESTIA
Cellestia is a clinical stage R&D company developing innovative first-in-class therapies to control and modulate pathogenic gene expression in multiple disease areas by selective inhibition of transcription factors in the cell nucleus. The lead compound CB-103 has advanced to Phase 2 successfully treating patients with multi-drug resistant cancers. Further, Cellestia is advancing a rich R&D pipeline of novel transcription factor inhibitors, in oncology, auto-immune and inflammatory disorders, having achieved animal in-vivo proof of concept for several new targets. Cellestia was founded in 2014 as a spin-off from EPFL, Lausanne, Switzerland and is headquartered in Basel, Switzerland.
CELLESTIA
Industry:
Biopharma Biotechnology Health Care Therapeutics
Founded:
2014-01-01
Address:
Basel, Basel-Stadt, Switzerland
Country:
Switzerland
Website Url:
http://www.cellestia.com
Total Employee:
11+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
48.72 M USD
Technology used in webpage:
SPF Microsoft Exchange Online Office 365 Mail OVH
Similar Organizations
Regulaxis SAS
Regulaxis is focused in research, development and licensing of human innovative synthetic molecules for high unmet medical needs
Reapplix
Reapplix identifies blood-derived proteins that improve wound healing, isolates them, and reapplies them to patients with chronic wounds.
NorthSea Therapeutics
NorthSea Therapeutics is a clinical-stage biotech company developing first-in class, oral, structurally-engineered lipid therapeutics.
Naurex
Naurex is a clinical-stage company developing novel therapeutics for depression and other CNS disorders.
Navega Therapeutics
Navega Tx is a preclinical stage company pursuing a radically different approach to treat chronic pain and tackle the opioid epidemic.
Verseau Therapeutics
Verseau focus is building a pipeline of first-in-class therapies that modulate macrophages to trigger a coordinated immune attack on cancer.
VECT-HORUS
VECT-HORUS is a biotechnology company that develops peptide-based vectors facilitating the drug delivery or imaging agents into the brain.
Milis Bio
MilisBio is developing a sugar substitute from protein that will satiate Their cravings without harming their health.
Mecwins
Mecwins uses its own technology to produce ultra-high sensitive immunoassays for oncology, cardiovascular and infectious diseases.
Marinomed
Marinomed is a biopharmaceutical company that develops innovative anti-viral and immunological treatments.
Mogrify
Mogrify® will transform the development of ex vivo cell therapies and pioneer a new class of in vivo reprogramming therapies.
Microbiotica
Microbiotica is a developer of human microbiome therapeutics intended to discover and develop live bacterial therapeutics and biomarkers.
Midatech Pharma
Midatech Pharma a particle engineering with an emphasis on microfluidics and drug delivery.
MediSieve
MediSieve is a therapeutics company developing a platform technology for the treatment of blood-borne diseases.
21st.BIO
21st Bio has the potential to replace and improve a wide range of meals and materials with appealing sustainable bio-based alternatives.
LNC Therapeutics
LNC Therapeutics is developing gut microbiota directed drugs to target obesity and associated cardiometabolic diseases.
Lineage Cell Therapeutics
Lineage Cell Therapeutics is a clinical-stage biotechnology company developing novel cellular therapies to treat unmet medical needs.
LabGenius
LabGenius is a biopharmaceutical company developing protein therapeutics using a machine learning-driven evolution engine.
AgomAb Therapeutics
AgomAb Therapeutics is a Company is developing growth factor-mimetic agonistic monoclonal antibodies to regenerate damaged tissues.
amcure
amcure is a clinical-stage company develops peptide-based compounds for the treatment of highly metastatic forms of squamous cancer.
Alentis Therapeutics
ALENTIS Therapeutics is a Swiss-French biotech company developing novel therapeutics in advanced liver disease and cancer.
Acticor Biotech
Acticor Biotech is a biopharmaceutical company developing an innovative drug for the treatment in the acute phase of ischemic stroke.
Advanced BioDesign
Advanced BioDesign as an immunotechnology specialist, provides a tailored and high value solution.
ADC Biotechnology
ADC BIO is an innovative biotechnology company. Specialising in Antibody Drug Conjugates.
Allakos
Allakos is a biotechnology company that develops antibody-based therapeutics to treat various allergies and diseases.
AZTherapies
AZTherapies is a clinical stage biotech company developing breakthrough treatments for neuroinflammation-related diseases.
ALX Oncology
ALX Oncology is a preclinical stage biotechnology company developing innovative immuno-oncology therapies for cancer.
ATAI Life Sciences
ATAI Life Sciences develops innovative mental health treatments that address significant unmet medical needs.
Avalon GloboCare Corp
Avalon GloboCare Corp is a clinical-stage CellTech bio-developer dedicated to Advancing and Empowering Innovative and Exosome Technology.
audibene
audibene is the fastest growing hearing care company ever. Our vision is to help everyone hear well to live well.
AYOXXA
AYOXXA is a biotech company commercializing innovative technology.
Altheia Science
Altheia Science is transforming the life of patients with autoimmune diseases throught innovative and curative cell and gene therapies.
Exonate
Exonate is a biotech company spun out of the University of Nottingham that is focused on alternative splicing of (VEGF) in ophthalmology.
ENTEROME
Enterome is a clinical-stage company developing drugs for chronic medical conditions relating to abnormalities of bacterial composition.
Emergex Vaccines
Pioneering a new approach to vaccine development and manufacturing using cutting-edge technologies to produce novel synthetic vaccines.
ExeVir Bio
ExeVir Bio is a Belgium-based company that develops single-domain antibody-based therapies that help patients ward off viral infections.
BeneVir Biopharm
Maryland startup BeneVir is developing immunotherapy viruses that rid the body of two types of tumor cells.
FIRE1
FIRE1 and is based in Dublin, Ireland, will focus on developing novel therapeutic devices.
ForMune
ForMune is a medical-based company developing therapeutic vaccines and molecules for subsequent license.
Thousand Oaks Biopharmaceuticals
Thousand Oaks Biopharmaceuticals is a developer of biopharmaceutical technologies intended to produce protein and vaccine compounds.
TC BioPharm
TC BioPharm developing safer, cheaper, consistent and durable CAR-T drugs for hematological and solid tumors.
TreeFrog Therapeutics
TreeFrog Therapeutics is a stem cell company that will enable millions of patients to access the medical revolution of cell therapies.
Treeway
Treeway accelerates ALS (Amyotrophic Lateral Sclerosis) therapy development.
Theravectys
Theravectys develops a platform for the prevention and treatment of cancers and other infectious diseases and conditions.
Turbine
Turbine's platform understands the inner mechanisms of cancer enabling the discovery of novel targets & precision medicinal therapies.
Unobravo | Telehealth & psychology platform
Unobravo is a platform that matches people looking for psychological support with the therapist best suited to support them.
Uniq Bioresearch
Uniq Bioresearch is a biotechnology company that develops new whey protein based whey protein product and microencapsulation concepts.
QUE Oncology
QUE Oncology develops novel therapies to address unmet medical needs in the treatment of cancer and its consequences.
Kymab
Kymab is a clinical-stage biopharmaceutical company developing fully human monoclonal antibody therapeutics.
Kantum Pharma
Kantum Pharma is developing a specific AKI therapy to help critical care clinicians prevent hundreds of thousands of deaths from AKI.
Kinarus Therapeutics (SIX:KNRS)
Kinarus is focused on developing novel treatments for patients suffering from serious viral, respiratory, and ophthalmic diseases.
KaNDy Therapeutics
KaNDy Therapeutics is a clinical-stage company focused on optimising the potential of NT-814.
Salvia BioElectronics
Salvia is an innovative start-up active in the emerging field of BioElectronics.
SciNeuro
SciNeuro is a biotechnology company focused on developing innovative medicines for patients with central nervous system diseases.
SciRhom
SciRhom is a biotech enterprise that translate advanced scientific findings into game-changing therapies for autoimmune diseases.
Palisade Bio
Palisade Bio is a clinical-stage biopharmaceutical company developing novel therapies for acute and chronic gastrointestinal complications.
StemSight
StemSight is a cell therapy startup developing novel treatments for blindness operating in Tampere, Finland.
Stayble Therapeutics
Stayble Therapeutics is developing a minimally invasive injection-based treatment against chronic low back pain.
Syntaxis
Syntaxis is committed to discovering, developing and commercialising novel therapeutics that enhance recovery of brain functions.
Ducentis BioTherapeutics
Ducentis is a pre-clinical stage company that aims to develop novel therapies for inflammation and autoimmune disease.
DCPrime
DCPrime is a clinical stage company which develops novel cancer immunotherapies based on its DCOne platform technology.
Dopavision
Dopavision is a therapeutic company developing a digital therapeutic for myopia.
HiFiBiO
HiFiBiO provides proprietary single cell technologies for applications in drug and biomarker discovery and development.
Hookipa Pharma
Hookipa is a clinical stage biotech company developing best-in-class active immunization therapies for infectious diseases and oncology.
IO Biotech
IO Biotech is a clinical-stage biotech company developing disruptive immune therapies for the treatment of cancer.
GamaMabs Pharma
GamaMabs Pharma is a clinical-stage immuno-oncology company that developes optimized therapeutic antibodies for the treatment of cancer.
Ochre Bio
Ochre Bio is a biotechnology company that develops and builds a deep phenotyping platform to rejuvenate transplant livers.
OncoResponse
OncoResponse is a company providing cancer research into immunotherapies and the newest technologies for oncologists.
Osivax
Osivax is a clinical stage biotechnology company developing a pipeline of vaccines and immunotherapies.
Oxford MEStar
Oxford MEStar is specialising in translational and regenerative medicine.
Orbit Discovery
Orbit Discovery is a peptide display company identifying potential peptide drugs for a range of chronic diseases.
OncoOne
OncoOne is a biotech start-up dedicated to developing innovative therapeutics.
ZZ Biotech
A clinical stage company developing innovative biologic treatments for ischemic stroke.
ChemoTech
ChemoTech is an innovator in gentle cancer treatment and effective pain management.
Camallergy
Camallergy develops and provides new treatments for common food allergies.
CarThera
CarThera designs and develops innovative therapeutic ultrasound-based medical devices for treating brain disorders.
Carbiotix
Carbiotix is a pre-clinical stage therapeutics company focusing on low-cost gut health testing and microbiome modulators.
Complix
Complix is a biopharmaceutical company developing Alphabodies, a novel class of biopharmaceuticals.
Carlina Technologies
Company specialized in the development of nanomedicines utilizing innovative controlled drug delivery technology platforms.
Coya Therapeutics
Coya Therapeutics is a cell therapy platform company that develops first-in-class therapeutics for ALS and other neurodegenerative diseases.
CureTech
CureTech is a biotechnology company developing immune modulating products to treat and control cancer.
Cytovant
Cytovant is a biopharmaceutical company focused on developing novel and innovative cellular therapeutics.
Cellaria
Cellaria provides cancer research, patient testing, and treatment development.
Protein Alternatives
ProAlt is young biotech company developing innovative products for the detection and treatment of cancers.
PDC*line Pharma
PDC*line Pharma develops a new class of active immunotherapies for cancer based on an allogeneic cell line of Plasmacytoid Dendritic cells.
Phico Therapeutics
Phico Therapeutics is a developer of novel platform technology designed to overcome antibacterial resistance.
PathoQuest
PathoQuest is a biotech company developing NGS-based metagenomic tests for exhaustive identification of pathogens.
Printivo Group Jsc
3D-bioprinting company in a mission to improve drug-testing and personalized medical therapies through complete printed human organ.
Current Employees Featured
Founder
Investors List
SNGLR Capital AG
SNGLR Capital AG investment in Venture Round - Cellestia
FC Capital
FC Capital investment in Series B - Cellestia
PPF Group
PPF Group investment in Series B - Cellestia
Partners Investment
Partners Investment investment in Series B - Cellestia
EASME - EU Executive Agency for SMEs
EASME - EU Executive Agency for SMEs investment in Grant - Cellestia
FC Capital
FC Capital investment in Series A - Cellestia
ETP Ventures
ETP Ventures investment in Series A - Cellestia
Emerging Technology Partners
Emerging Technology Partners investment in Series A - Cellestia
PPF Group
PPF Group investment in Series A - Cellestia
GoBeyond
GoBeyond investment in Series A - Cellestia
Official Site Inspections
http://www.cellestia.com
- Host name: hypnos.labonneagence.com
- IP address: 176.31.68.81
- Location: France
- Latitude: 48.8582
- Longitude: 2.3387
- Timezone: Europe/Paris
